CLINICAL_TRIALS
other
· 2025-09-09
Clinical Trial Update: UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study [Phase 2]
Summary
Phase II clinical trial update for UBT251 in type 2 diabetes mellitus indicates the study is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The United Bio-Technology (Hengqin) Co., Ltd. | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 2 | Status: ACTIVE_NOT_RECRUITING